ALK-positive lung cancer: a moving target
Jaime L. Schneider, Jessica J. Lin, Alice T. Shaw
Topics & Concepts
Anaplastic lymphoma kinaseLung cancerCrizotinibALK inhibitorCancer researchTyrosine kinaseAcquired resistanceMedicineDrug resistanceTyrosine-kinase inhibitorTargeted therapyCancerBiologyOncologyInternal medicineGeneticsReceptorMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer therapeutics and mechanisms